Assura Group /£AGR

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Assura Group

Assura Group, operating under the ticker AGR, is a UK-based real estate investment trust (REIT) specializing in healthcare premises. Established in 2003 and headquartered in Warrington, it focuses on developing, investing in, and managing a portfolio of primary care facilities. Assura's properties primarily serve the healthcare sector by housing GP surgeries, NHS outpatient services, and pharmacies, thereby supporting the delivery of community-based healthcare services.

Ticker

£AGR

Primary listing

LSE

Employees

86

Assura Group Metrics

BasicAdvanced
£1.5B
9.05
£0.05
0.62
£0.03
7.06%

What the Analysts think about Assura Group

Analyst ratings (Buy, Hold, Sell) for Assura Group stock.

Bulls say / Bears say

Assura Group returned to a full-year pretax profit of £4.4 million for the year ended March 31, 2025, versus a £99.7 million loss a year prior, with revenue up 17.2%, and the REIT announced dividend payments will resume, indicating a solid operational turnaround and strengthened cash flows. (Reuters)
Assura shareholders accepted a takeover offer from KKR and Stonepeak worth £1.61 billion, or 49.4 pence per share with a quarterly interim dividend, marking a 33.5% premium to its February 13 share price and reflecting external confidence in Assura’s asset values. (Reuters)
KKR and Stonepeak raised their all-cash bid to 52.1 pence per share in June 2025—a 39% premium on Assura’s pre-bid share price—demonstrating strong demand for Assura’s portfolio of more than 600 healthcare properties valued at over £3 billion. (Reuters)
The protracted bidding battle between KKR-Stonepeak and Primary Health Properties has brought strategic uncertainty and management distraction, potentially hindering Assura’s ability to focus on its main development and asset management activities. (Reuters)
KKR-Stonepeak’s all-cash acquisition offer plans to delist Assura from the LSE and halt public dividend payments after completion, which may reduce liquidity and ongoing income streams for minority shareholders. (Reuters)
The hefty takeover premiums in successive offers suggest that Assura’s valuation could have peaked near current bid levels, capping potential gains for remaining public investors unless further rival bids or alternative strategies emerge. (Reuters) (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 6 Oct 2025.

Assura Group Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Assura Group Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £AGR

Sign up or log in to buy
Capital at risk
Market closedInternal

Upcoming events

No upcoming events
FAQs